Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Pomegranate peel compounds may help treat hair loss.

The skin produces and processes hormones, affecting both local and overall body functions.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

A girl with a rare skin condition called Keratosis Follicularis Spinulosa Decalvans showed no significant improvement with treatment.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

The skin acts like an endocrine organ, producing hormones that affect various body functions and skin health, and understanding this can lead to new treatments.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Plum-blossom needling with conventional treatments improves hair regrowth in alopecia areata.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Genetic testing confirmed a rare skin disorder in a young girl, which improved with zinc supplementation.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Current treatments for alopecia show no significant long-term benefits.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Finasteride may cause slight depression and anxiety.